Israel Chemicals Ltd (ICL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 473,000 | 301,000 | 318,000 | 157,000 | 214,000 |
| Marketable Securities | 91,000 | 191,000 | 272,000 | 99,000 | 153,000 |
| Receivables | 1,775,000 | 1,560,000 | 1,441,000 | 1,537,000 | 1,224,000 |
| Inventories | 1,570,000 | 1,409,000 | 1,207,000 | 1,195,000 | 1,250,000 |
| TOTAL | $3,909,000 | $3,461,000 | $3,238,000 | $2,988,000 | $2,841,000 |
| Non-Current Assets | |||||
| PPE Net | 5,754,000 | 5,632,000 | 5,601,000 | 5,531,000 | 5,550,000 |
| Investments And Advances | 0 | 0 | 0 | 0 | 83,000 |
| Intangibles | 867,000 | 927,000 | 725,000 | 709,000 | 670,000 |
| Other Non-Current Assets | 550,000 | 552,000 | 516,000 | 492,000 | 520,000 |
| TOTAL | $7,171,000 | $7,111,000 | $6,842,000 | $6,732,000 | $6,823,000 |
| Total Assets | $11,080,000 | $10,572,000 | $10,080,000 | $9,720,000 | $9,664,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 577,000 | 597,000 | 630,000 | 617,000 | 679,000 |
| Accounts payable and accrued liabilities | 1,976,000 | 885,000 | 801,000 | 752,000 | 740,000 |
| Other current liabilities | 59,000 | 56,000 | 55,000 | 54,000 | 758,000 |
| TOTAL | $2,612,000 | $2,278,000 | $2,145,000 | $2,158,000 | $2,177,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,436,000 | 2,426,000 | 2,212,000 | 2,121,000 | 2,053,000 |
| Other Non-Current Liabilities | 897,000 | 938,000 | 966,000 | 950,000 | 1,015,000 |
| TOTAL | $3,732,000 | $3,772,000 | $3,556,000 | $3,398,000 | $3,399,000 |
| Total Liabilities | $6,344,000 | $6,050,000 | $5,701,000 | $5,556,000 | $5,576,000 |
| Shareholders' Equity | |||||
| Common Shares | 548,000 | 547,000 | 547,000 | 546,000 | 546,000 |
| Retained earnings | 4,321,000 | 4,106,000 | 3,941,000 | 3,861,000 | 3,752,000 |
| Other shareholders' equity | -235,000 | -233,000 | -177,000 | -233,000 | -176,000 |
| TOTAL | $4,736,000 | $4,522,000 | $4,379,000 | $4,164,000 | $4,088,000 |
| Total Liabilities And Equity | $11,080,000 | $10,572,000 | $10,080,000 | $9,720,000 | $9,664,000 |